2 completed, 2 recruiting, 1 not yet recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Agomab Spain S.L.U.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis AGMB-447, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Not yet recruiting | Agomab Spain S.L.U. | 120 | 2026-11-30 | 2026-10-07 |
| NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease Ontunisertib, Placebo - Fibrostenotic Crohn's Disease | Phase 2 | Recruiting | Agomab Spain S.L.U. | 320 | 2026-10-30 | 2026-10-19 |
| Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers Ontunisertib, [14C]ontunisertib - Fibrostenotic Crohn's Disease | Phase 1 | Recruiting | Agomab Spain S.L.U. | 8 | 2026-09-09 | 2026-09-11 |
| A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants AGMB-129, Placebo - Fibrostenotic Crohn's Disease | Phase 1 | Completed | Agomab Spain S.L.U. | 30 | 2025-08-06 | 2025-11-21 |
| STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease AGMB-129, Placebo - Fibrostenotic Crohn's Disease | Phase 2 | Completed | Agomab Spain S.L.U. | 103 | 2023-08-01 | 2026-07-09 |
Idiopathic Pulmonary Fibrosis (1)
United States (2) · Austria (1) · Belgium (1) · Canada (1) · Denmark (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1)
Carmen Fleurinck, MD (1) · Kay Tetzlaff, MD (1) · Philippe Wiesel, MD (1)
2025 (1)